Pharmaceutical giant Pfizer has announced it planned to submit a COVID-19 vaccine for children under the age of 5 to the Food and Drug Administration (FDA) of the United for emergency authorization.
Coronavirus disease 2019 (COVID-19) vaccines are available to children in the U.S. Here's what parents need to know about the safety and effectiveness of the vaccine, the possible side effects ...
Only myocarditis/pericarditis and seizures occurred at higher rates in adolescents and children vaccinated for COVID-19 when ...
GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
Changes in the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related hospitalizations.
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...
A new study from the CDC states that there is no data to support an association between the COVID vaccines and sudden cardiac death among previously healthy young persons The COVID-19 vaccines are ...
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11, the White House said Monday. The first ...
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...